People Science

Cannabis genetics company Phylos, in partnership with People Science, conducted an Institutional Review Board-approved, double-blind clinical study on the effects of rare cannabinoid tetrahydrocannabivarin (THCV). According to the research, Natural Natural THCV developed by Phylos resulted in...

Private biopharma company People Science raised $5.3 million in its second seed round, which was led by Acre Venture Partners and followed by Bluestein Ventures, THIA Ventures and FORM Life Ventures. The company, which now has a total $8.5 million of seed funding, will use the latest capital to...